Share-based Payment Arrangement, Expense in USD of VivoSim Labs, INC. from 2014 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
VivoSim Labs, INC. quarterly and annual Share-based Payment Arrangement, Expense history and change rate from 2014 to Q3 2025.
  • VivoSim Labs, INC. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $72,000, a 53.5% decline year-over-year.
  • VivoSim Labs, INC. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $371,000, a 44.5% decline year-over-year.
  • VivoSim Labs, INC. annual Share-based Payment Arrangement, Expense for 2024 was $532,000, a 64.7% decline from 2023.
  • VivoSim Labs, INC. annual Share-based Payment Arrangement, Expense for 2023 was $1,508,000, a 36.6% decline from 2022.
  • VivoSim Labs, INC. annual Share-based Payment Arrangement, Expense for 2022 was $2,377,000, a 5.36% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

VivoSim Labs, INC. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $371,000 $72,000 -$83,000 -53.5% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q2
Q2 2025 $454,000 $78,000 -$78,000 -50% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2025 Q1
Q1 2025 $532,000 $91,000 -$110,000 -54.7% 01 Jan 2025 31 Mar 2025 10-K 05 Jun 2025 2025 FY
Q4 2024 $642,000 $130,000 -$27,000 -17.2% 01 Oct 2024 31 Dec 2024 10-Q 19 Feb 2025 2025 Q3
Q3 2024 $669,000 $155,000 -$520,000 -77% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q2
Q2 2024 $1,189,000 $156,000 -$319,000 -67.2% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025 2025 Q1
Q1 2024 $1,508,000 $201,000 -$299,000 -59.8% 01 Jan 2024 31 Mar 2024 10-K 05 Jun 2025 2025 FY
Q4 2023 $1,807,000 $157,000 -$387,000 -71.1% 01 Oct 2023 31 Dec 2023 10-Q 19 Feb 2025 2025 Q3
Q3 2023 $2,194,000 $675,000 +$2,000 +0.3% 01 Jul 2023 30 Sep 2023 10-Q 08 Nov 2024 2025 Q2
Q2 2023 $2,192,000 $475,000 -$185,000 -28% 01 Apr 2023 30 Jun 2023 10-Q 05 Aug 2024 2025 Q1
Q1 2023 $2,377,000 $500,000 -$327,000 -39.5% 01 Jan 2023 31 Mar 2023 10-K 31 May 2024 2024 FY
Q4 2022 $2,704,000 $544,000 -$44,000 -7.48% 01 Oct 2022 31 Dec 2022 10-Q 08 Feb 2024 2023 Q3
Q3 2022 $2,748,000 $673,000 +$247,000 +58% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q2
Q2 2022 $2,501,000 $660,000 +$245,000 +59% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q1
Q1 2022 $2,256,000 $827,000 +$540,000 +188% 01 Jan 2022 31 Mar 2022 10-K 14 Jul 2023 2023 FY
Q4 2021 $1,716,000 $588,000 +$382,000 +185% 01 Oct 2021 31 Dec 2021 10-Q 09 Feb 2023 2023 Q3
Q3 2021 $1,334,000 $426,000 -$3,712,000 -89.7% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2023 Q2
Q2 2021 $5,046,000 $415,000 -$510,000 -55.1% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022 2023 Q1
Q1 2021 $5,556,000 $287,000 -$113,000 -28.2% 01 Jan 2021 31 Mar 2021 10-K 10 Jun 2022 2022 FY
Q4 2020 $5,669,000 $206,000 -$1,046,000 -83.5% 01 Oct 2020 31 Dec 2020 10-Q 14 Feb 2022 2022 Q3
Q3 2020 $6,715,000 $4,138,000 +$2,902,000 +235% 01 Jul 2020 30 Sep 2020 10-Q 08 Nov 2021 2022 Q2
Q2 2020 $3,813,000 $925,000 -$295,000 -24.2% 01 Apr 2020 30 Jun 2020 10-Q 06 Aug 2021 2022 Q1
Q1 2020 $4,108,000 $400,000 -$882,000 -68.8% 01 Jan 2020 31 Mar 2020 10-K 15 Jun 2021 2021 FY
Q4 2019 $4,990,000 $1,252,000 -$106,000 -7.81% 01 Oct 2019 31 Dec 2019 10-Q 08 Feb 2021 2021 Q3
Q3 2019 $5,096,000 $1,236,000 -$38,000 -2.98% 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2020 2021 Q2
Q2 2019 $5,134,000 $1,220,000 -$59,000 -4.61% 01 Apr 2019 30 Jun 2019 10-Q 10 Aug 2020 2021 Q1
Q1 2019 $5,193,000 $1,282,000 -$21,000 -1.61% 01 Jan 2019 31 Mar 2019 10-K 28 May 2020 2020 FY
Q4 2018 $5,214,000 $1,358,000 +$108,000 +8.64% 01 Oct 2018 31 Dec 2018 10-Q 10 Feb 2020 2020 Q3
Q3 2018 $5,106,000 $1,274,000 -$1,024,000 -44.6% 01 Jul 2018 30 Sep 2018 10-Q 07 Nov 2019 2020 Q2
Q2 2018 $6,130,000 $1,279,000 -$773,000 -37.7% 01 Apr 2018 30 Jun 2018 10-Q 08 Aug 2019 2020 Q1
Q1 2018 $6,903,000 $1,303,000 -$549,000 -29.6% 01 Jan 2018 31 Mar 2018 10-K 03 Jun 2019 2019 FY
Q4 2017 $7,452,000 $1,250,000 -$768,000 -38.1% 01 Oct 2017 31 Dec 2017 10-Q 07 Feb 2019 2019 Q3
Q3 2017 $8,220,000 $2,298,000 +$205,000 +9.8% 01 Jul 2017 30 Sep 2017 10-Q 08 Nov 2018 2019 Q2
Q2 2017 $8,015,000 $2,052,000 +$623,000 +43.6% 01 Apr 2017 30 Jun 2017 10-Q 09 Aug 2018 2019 Q1
Q1 2017 $7,392,000 $1,852,000 01 Jan 2017 31 Mar 2017 10-K 31 May 2018 2018 FY
Q4 2016 $2,018,000 01 Oct 2016 31 Dec 2016 10-Q 08 Feb 2018 2018 Q3
Q3 2016 $2,093,000 01 Jul 2016 30 Sep 2016 10-Q 09 Nov 2017 2018 Q2
Q2 2016 $1,429,000 01 Apr 2016 30 Jun 2016 10-Q 09 Aug 2017 2018 Q1

VivoSim Labs, INC. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $532,000 -$976,000 -64.7% 01 Apr 2024 31 Mar 2025 10-K 05 Jun 2025 2025 FY
2023 $1,508,000 -$869,000 -36.6% 01 Apr 2023 31 Mar 2024 10-K 05 Jun 2025 2025 FY
2022 $2,377,000 +$121,000 +5.36% 01 Apr 2022 31 Mar 2023 10-K 31 May 2024 2024 FY
2021 $2,256,000 -$3,300,000 -59.4% 01 Apr 2021 31 Mar 2022 10-K 14 Jul 2023 2023 FY
2020 $5,556,000 +$1,448,000 +35.2% 01 Apr 2020 31 Mar 2021 10-K 10 Jun 2022 2022 FY
2019 $4,108,000 -$1,085,000 -20.9% 01 Apr 2019 31 Mar 2020 10-K 15 Jun 2021 2021 FY
2018 $5,193,000 -$1,710,000 -24.8% 01 Apr 2018 31 Mar 2019 10-K 28 May 2020 2020 FY
2017 $6,903,000 -$489,000 -6.62% 01 Apr 2017 31 Mar 2018 10-K 03 Jun 2019 2019 FY
2016 $7,392,000 -$1,164,000 -13.6% 01 Apr 2016 31 Mar 2017 10-K 31 May 2018 2018 FY
2015 $8,556,000 +$1,536,000 +21.9% 01 Apr 2015 31 Mar 2016 10-K 31 May 2018 2018 FY
2014 $7,020,000 01 Apr 2014 31 Mar 2015 10-K 07 Jun 2017 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.